A Phase 3 Randomized Double-blind Study Comparing TR-701 FA and Linezolid in Ventilated Gram-positive Nosocomial Pneumonia
Phase of Trial: Phase III
Latest Information Update: 02 Aug 2017
At a glance
- Drugs Tedizolid (Primary) ; Linezolid
- Indications Nosocomial pneumonia
- Focus Registrational; Therapeutic Use
- Sponsors Cubist Pharmaceuticals; Merck Sharp & Dohme; Trius Therapeutics
- 10 May 2017 This trial has been completed in Austria.
- 29 Nov 2016 Planned End Date changed from 1 Jan 2018 to 1 Oct 2018.
- 29 Nov 2016 Planned primary completion date changed from 1 Jan 2018 to 1 Oct 2018.